Precision medicine and the antiphospholipid syndrome: what is the future?
- PMID: 32060811
- DOI: 10.1007/s10067-020-04987-8
Precision medicine and the antiphospholipid syndrome: what is the future?
References
-
- Duarte-García A, Pham MM, Crowson CS, Amin S, Moder KG, Pruthi RK, Warrington KJ, Matteson EL (2019) The epidemiology of antiphospholipid syndrome: a population-based study. Arthritis Rheum. 71(9):1545–1552
-
- Cervera R, Serrano R, Pons-Estel GJ et al (2015) Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann. Rheum. Dis. 74(6):1011–1018 http://www.ncbi.nlm.nih.gov/pubmed/24464962 .
-
- Asherson RA (1992) The catastrophic antiphospholipid syndrome. J. Rheumatol. 19(4):508–512 http://www.ncbi.nlm.nih.gov/pubmed/1593568 .
-
- Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. : JTH 4(2):295–306 http://www.ncbi.nlm.nih.gov/pubmed/16420554 .
-
- Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, Dörner T, Ferrer-Oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-Irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM (2019) EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78(10):1296–1304
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
